APA (7th ed.) Citation

Gray, A., Clarke, P., Raikou, M., Adler, A., Stevens, R., Neil, A., . . . Holman, R. (2001). An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54). Diabetic medicine, 18(6), 438-444. https://doi.org/10.1046/j.1464-5491.2001.00485.x

Chicago Style (17th ed.) Citation

Gray, A., P. Clarke, M. Raikou, A. Adler, R. Stevens, A. Neil, C. Cull, I. Stratton, and R. Holman. "An Economic Evaluation of Atenolol Vs. Captopril in Patients with Type 2 Diabetes (UKPDS 54)." Diabetic Medicine 18, no. 6 (2001): 438-444. https://doi.org/10.1046/j.1464-5491.2001.00485.x.

MLA (9th ed.) Citation

Gray, A., et al. "An Economic Evaluation of Atenolol Vs. Captopril in Patients with Type 2 Diabetes (UKPDS 54)." Diabetic Medicine, vol. 18, no. 6, 2001, pp. 438-444, https://doi.org/10.1046/j.1464-5491.2001.00485.x.